Severe Acute Respiratory Syndrome clinical trials at UC Irvine

1 research study open to eligible people

Double-Blind, Randomized, Placebo-Controlled, Adaptive Design, Multi-Center Phase 3 Study to Evaluate the Efficacy and Safety of Fostamatinib in COVID-19 Subjects
open to eligible people ages 18-100
The study is a double-blind, randomized, placebo-controlled, adaptive design, multi-center, Phase 3 study to evaluate the efficacy and safety of fostamatinib in COVID-19 subjects.
Orange, California and other locations

Last updated: June 28, 2021